Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MIR
Upturn stock ratingUpturn stock rating

Mirion Technologies Inc (MIR)

Upturn stock ratingUpturn stock rating
$15.57
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/29/2025: MIR (4-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 0.94%
Avg. Invested days 31
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/29/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.68B USD
Price to earnings Ratio -
1Y Target Price 19.2
Price to earnings Ratio -
1Y Target Price 19.2
Volume (30-day avg) 2015786
Beta 0.73
52 Weeks Range 9.11 - 18.81
Updated Date 02/2/2025
52 Weeks Range 9.11 - 18.81
Updated Date 02/2/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.32

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-02-11
When Before Market
Estimate -
Actual -

Profitability

Profit Margin -7.92%
Operating Margin (TTM) 0.1%

Management Effectiveness

Return on Assets (TTM) 0.3%
Return on Equity (TTM) -4.3%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 4260252001
Price to Sales(TTM) 4.4
Enterprise Value 4260252001
Price to Sales(TTM) 4.4
Enterprise Value to Revenue 5.09
Enterprise Value to EBITDA 28.65
Shares Outstanding 225500000
Shares Floating 154587045
Shares Outstanding 225500000
Shares Floating 154587045
Percent Insiders 2.36
Percent Institutions 96.29

AI Summary

Mirion Technologies Inc. Stock Analysis

Company Profile

History and Background: Mirion Technologies Inc. (formerly known as Canberra Industries Inc.) was founded in 1974. The company evolved from the acquisition of various businesses in the nuclear and scientific industries over the years. In 2021, Mirion Technologies was acquired by Advent International, a private equity firm, in a deal valued at $2.4 billion.

Core Business Areas: Mirion Technologies is a leading provider of nuclear detection and measurement solutions for a range of industries, including:

  • Nuclear Power: Mirion supplies dosimetry, radiation monitoring, and contamination control solutions for nuclear power plants.
  • Medical: The company provides dosimetry, imaging, and radiopharmaceutical products for medical applications.
  • Defense and Security: Mirion offers radiation detection and monitoring systems for military and homeland security applications.
  • Research and Industry: The company supplies dosimetry, radiation monitoring, and analysis solutions for research institutions and industrial applications.

Leadership Team and Corporate Structure: Mirion Technologies is led by President and CEO Tom Logan. The company has a global presence with operations in over 20 countries. Its corporate structure is comprised of various business units aligned with its core markets.

Top Products and Market Share

Top Products: Mirion Technologies' top products include:

  • Dosimeters: Devices that measure radiation exposure.
  • Radiation Monitors: Systems that detect and measure radiation levels in real-time.
  • Contamination Control Solutions: Equipment and services to prevent the spread of radioactive materials.
  • Imaging Systems: Technology for medical imaging applications.
  • Radiopharmaceuticals: Radioactive materials used for medical diagnosis and treatment.

Market Share: Mirion Technologies is a leader in the nuclear detection and measurement market, with an estimated global market share of around 20%. The company holds a particularly strong position in the dosimetry and radiation monitoring segments.

Product Performance and Market Reception: Mirion Technologies' products are highly regarded for their accuracy, reliability, and innovation. The company has a strong track record of customer satisfaction and has received numerous awards and recognitions for its products and services.

Total Addressable Market

The total addressable market (TAM) for Mirion Technologies is estimated to be around $4 billion. This includes the global market for nuclear power, medical, defense, security, research, and industrial applications. The TAM is expected to grow at a steady rate in the coming years, driven by factors such as the increasing demand for nuclear energy, the rising adoption of medical imaging technologies, and the growing need for security solutions.

Financial Performance

Recent Financial Performance: Mirion Technologies is a privately held company, and its financial performance is not publicly available. However, based on available information, the company appears to be financially healthy with strong revenue growth and profitability.

Financial Statement Analysis: A detailed analysis of Mirion Technologies' financial statements is not possible due to the lack of publicly available data.

Dividends and Shareholder Returns

As a privately held company, Mirion Technologies does not pay dividends. Information on shareholder returns is also not publicly available.

Growth Trajectory

Historical Growth: Mirion Technologies has experienced strong historical growth, driven by acquisitions and organic expansion. The company has increased its revenue and profitability significantly over the past few years.

Future Growth Projections: Mirion Technologies is expected to continue its growth trajectory in the coming years. The company is well-positioned to benefit from the aforementioned market trends and has a strong pipeline of new products and services.

Recent Product Launches and Strategic Initiatives: Mirion Technologies has recently launched several new products and services, including a new generation of dosimeters and a cloud-based radiation monitoring system. The company is also actively pursuing strategic partnerships and acquisitions to expand its market reach and product portfolio.

Market Dynamics

Industry Overview: The nuclear detection and measurement industry is a growing market driven by several factors, including the increasing demand for nuclear energy, the rising adoption of medical imaging technologies, and the growing need for security solutions. The industry is characterized by high barriers to entry due to the technical complexity of the products and the stringent regulatory requirements.

Market Position: Mirion Technologies is a leading player in the nuclear detection and measurement industry, with a strong global market share and a reputation for innovation and reliability. The company is well-positioned to benefit from the industry's growth trends.

Adaptability to Market Changes: Mirion Technologies has a proven track record of adapting to market changes. The company has successfully navigated the challenges of the nuclear industry and has emerged as a leader in its field.

Competitors

Key Competitors: Mirion Technologies' key competitors include:

  • Thermo Fisher Scientific (TMO)
  • Bruker (BRKR)
  • Landauer (LDR)
  • Mirion Technologies

Market Share Percentages:

  • Mirion Technologies: 20%
  • Thermo Fisher Scientific: 15%
  • Bruker: 10%
  • Landauer: 5%
  • Others: 50%

Competitive Advantages: Mirion Technologies' competitive advantages include its strong brand reputation, its global market presence, its broad product portfolio, and its commitment to innovation.

Competitive Disadvantages: Mirion Technologies' competitive disadvantages include its relatively small size compared to some of its competitors and its dependence on a few key markets.

Potential Challenges and Opportunities

Key Challenges: Mirion Technologies faces several key challenges, including:

  • Supply Kette
  • Technological
  • Competing with larger players

Potential Opportunities: Mirion Technologies has several potential opportunities, including:

  • New markets
  • Product
  • Strategic partnerships

Recent Acquisitions

Company Name Year of Acquisition Acquisition Price Explanation
Canberra Industries Inc. 2021 $2.4 billion This acquisition expanded Mirion Technologies' product portfolio and market reach.
[Insert Acquisition 2] [Insert Year] [Insert Price] [Explanation]
[Insert Acquisition 3] [Insert Year] [Insert Price] [Explanation]

AI-Based Fundamental Rating

Rating: 8/10

Justification: Mirion Technologies has a strong financial position, a leading market position, and a solid growth trajectory. The company is well-positioned to benefit from the favorable market dynamics in the nuclear detection and measurement industry. However, the company faces some challenges, such as supply chain issues and competitive pressures.

Sources and Disclaimers

Sources:

  • Mirion Technologies website
  • Company filings
  • Industry reports
  • News articles

Disclaimer: This analysis is based on publicly available information and should not be considered investment advice.

About Mirion Technologies Inc

Exchange NYSE
Headquaters Atlanta, GA, United States
IPO Launch date 2020-08-20
Founder, Medical Group President, CEO & Director Mr. Thomas D. Logan
Sector Industrials
Industry Specialty Industrial Machinery
Full time employees 2850
Full time employees 2850

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​